Evidence map›Paper›PMID 35158743›Full record

ReviewCancers2022

Recent Advances on Immunohistochemistry and Molecular Biology for the Diagnosis of Adnexal Sweat Gland Tumors.

Nicolas Macagno, Pierre Sohier, Thibault Kervarrec, Daniel Pissaloux, Marie-Laure Jullie, Bernard Cribier, Maxime Battistella

Open access · goldAbstract readReview
In one paragraph

Review in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
11.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. S1 guideline sweat gland carcinoma.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Sweat gland carcinoma: a comprehensive review Part I: sweat gland carcinomas arising de novo.Virchows Archiv : an international journal of pathology · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Benign Cutaneous Neoplasms with Syndromic Associations.Dermatopathology (Basel, Switzerland) · 2025
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Nicolas MacagnoFrench Network of Rare Skin Cancers, CARADERM, France.ORCID 0000-0002-9882-2162
Pierre SohierFrench Network of Rare Skin Cancers, CARADERM, France.ORCID 0000-0002-2341-6848
Thibault KervarrecFrench Network of Rare Skin Cancers, CARADERM, France.
Daniel PissalouxDepartment of Biopathology, UNICANCER, Léon Bérard Center, 69008 Lyon, France.
Marie-Laure JullieFrench Network of Rare Skin Cancers, CARADERM, France.ORCID 0000-0002-0048-6501
Bernard CribierFrench Network of Rare Skin Cancers, CARADERM, France.
Maxime BattistellaFrench Network of Rare Skin Cancers, CARADERM, France.
Université de Tours · FRCentre Hospitalier Universitaire de Bordeaux · FRCentre National de la Recherche Scientifique · FRDélégation Paris 5 · FRInserm · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous sweat gland tumors are a subset of adnexal neoplasms that derive or differentiate into the sweat apparatus. Their great diversity, rarity, and complex terminology make their pathological diagnosis challenging. Recent findings have revealed a wide spectrum of oncogenic drivers, several of which are of diagnostic interest for pathologists. Most of these molecular alterations are represented by gene fusions, which are shared with other homologous neoplasms occurring in organs containing exocrine glands, such as salivary and breast glands, which show similarities to the sweat apparatus. This review aims to provide a synthesis of the most recent immunohistochemical and molecular markers used for the diagnosis of sweat gland tumors and to highlight their relationship with similar tumors in other organs. It will cover adenoid cystic carcinoma (

Indexed as

adenoid cystic carcinomaALKP1BRAFchondroid syringomaCYLDcylindromaETV6EWSR1FUShidradenomaHRASMAML2mixed tumorMYBMYBL1myoepitheliomaNFIBNTRK3NUTM1PLAG1porocarcinomaporoid hidradenomaporomasecretory carcinomaspiradenomasyringocystadenoma papilliferumtubular adenomaYAP1

Identifiers

PMID35158743
PMCPMC8833812
OpenAlexW4206447567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.